Search for: "Medimmune Inc" Results 1 - 20 of 248
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2022, 6:12 pm by Dennis Crouch
  This question ties the case directly to MedImmune, Inc. v. [read post]
20 Dec 2021, 8:42 am by Dennis Crouch
Hazeltine Research, Inc., 401 U.S. 321 (1971) (antitrust – patent pools – waiver of defenses); MedImmune, Inc. v. [read post]
14 Dec 2021, 9:57 am by Dennis Crouch
  As you can see, this question attempts to tie the case directly to MedImmune, Inc. v. [read post]
26 Oct 2021, 6:53 am by Unknown
Did the court of appeals err in adopting a new and inflexible rule,contrary to normal standing rules and this Court’s decision in MedImmune, Inc. [read post]
7 Jun 2021, 6:36 am by Dennis Crouch
The en banc petition focuses on the Supreme Court’s patent-licensee standing decision in MedImmune, Inc. v. [read post]
19 May 2021, 10:40 am by Dennis Crouch
”) Now, Apple has petitioned the Federal Circuit for en banc rehearing, arguing that the outcome is contrary to MedImmune Inc. v. [read post]
3 Aug 2020, 7:02 am by Elizabeth McAuliffe (Bristows)
The parties’ experts, Professor Patrick Wheeler of Nottingham University for Lufthansa and Mr Douglas Hay Barovsky of Engineering Systems Inc. for the Defendants disagreed on many points, in particular the identity of the skilled person. [read post]
2 Jun 2020, 1:50 pm by Dennis Crouch
  Later, in MedImmune, Inc. v. [read post]
28 Apr 2020, 11:46 pm by Brian Cordery (Bristows)
by Olivia Henry and Nicholas Michelmore On 20 April 2020, Arnold LJ (sitting as a High Court Judge) gave judgment in the case between FibroGen Inc and Astellas Pharma Inc (together the “Claimants”), and Akebia Therapeutics Inc and Otsuka Pharmaceutical Company Limited (together the “Defendants”) which concerned six patents owned by FibroGen and exclusively licensed to Astellas (the “Patents”). [read post]
24 May 2018, 8:53 pm by Patent Docs
Noonan -- Ever since the Supreme Court loosened the reins on declaratory judgment actions in patent cases twelve years ago, in MedImmune v. [read post]